Debbie Wake

BACKGROUND: MyWay Digital Health (MWDH) www.mwdh.co.uk is a purpose driven University of Dundee spin out company established in Jan 2017, currently supporting national and large regional data-integrated diabetes self-management platforms (globally) and since 2023, diabetes prevention, cardiovascular, hypertension and weight management. The original My Diabetes My Way (pre-commercial) product developed by University of Dundee, has been running nationally in Scotland since 2006. SOLUTION: MWDHs vision is to improve the lives of people living with diabetes (and now other long-term conditions) around the globe through cost effective data-driven personalised health technology solutions aimed at both patients and practitioners/ healthcare organisations. MyWay Health/ MyWay Diabetes Patient App (https://vimeo.com/440138386?share=copy) provides patient education (resources and courses), health data access, self-management support, semi-automated clinical services, including remote monitoring through pairing with remote diagnostics and device products. MyWay Clinical (https://vimeo.com/437674743/2e806dcca2)) is a complementary clinician platform supporting: i) individual/ population evidence-based management/ decision support, ii) risk profiling and analytics, iii) remote monitoring and patient secure messaging. MyWay IQ (MWIQ) is a predictive analytics tool supporting prediction of i) key short and long term complications, ii) individual response to drugs, iii) diagnosis of diabetes subtypes iv) self-management impact on outcomes. This can be used in conjunction with other MWDH products or as a stand-alone tool. MyWay Communications:Cohort Finding and Direct-to-Patient Marketing Services (SMS/ email) to support care pathways and recruitment into digital tools, national and local health programmes MyWay Diabetes (MWD) is MWDHs leading multi-award winning product, with >3.4m website/ education users, 18m pages viewed, 190,000 data app registrants, >23,000 structured course registrants. It is the number 1 diabetes app in UK (ORCHA score- 93%). MWD/ MDMW ingests NHS data for >1m people with diabetes and >0.5m with aligned metabolic conditions (covering 1,800 GP practices) supporting 26.8% of UK diabetes population including supporting the national NHS Scotland diabetes platform and NHS England’s national Type 1 online education service www.mytype1diabetes.nhs.uk;. MWDH has a Dubai office and commercial contracts in Saudi Arabia and developing partnerships/ projects in Asia.